ADHD

ADHD Frequently Co-Occurs with Autism Spectrum Disorder

April 05, 2018

The researchers found that 45.3% of the 3,319 children included in the analysis had ADHD. Comorbid ADHD increased with age (P<0.001) and was associated with increased ASD severity.

ADHD Incidence Increases Significantly Following Childhood TBI

March 20, 2018

The researchers found that 25.7% of the 187 children met the definition of SADHD. Compared with the OI group, severe TBI correlated with SADHD (hazard ratio [HR], 3.62; 95% confidence interval [CI], 1.59 to 8.26).

Adzenys ER Oral Suspension Launched for ADHD

By February 26, 2018

The once-daily medication uses the same modified-release drug delivery technology seen in Adzenys XR-ODT (amphetamine) Extended-Release Orally Disintegrating Tablets.

Is There Any Link Between Ultrasound Exposure and Autism?

February 14, 2018

The ASD group had a shorter duration of ultrasound exposure than the typical development group during the first (290.4 versus 406.4 seconds) and second (1,687.6 versus 2,011 seconds) trimesters. Greater mean depth of ultrasonographic penetration was seen in the ASD group versus the developmental delay group in the first trimester (12.5 versus 11.6 cm).

Are Psychiatric Drugs Being Overprescribed in Children and Adolescents?

By January 30, 2018

"Our results show that, at a population level, prescriptions of stimulants and antidepressant medications for children and adolescents do not appear to be prescribed at rates higher than the known rates for psychiatric conditions they are designed to treat," said the study's lead author, Dr. Ryan Sultan.

AHRQ: Update on ADHD Diagnosis and Treatment

By January 26, 2018

Evidence was contributed from 103 articles describing 90 unique studies.

Shortage of Two ADHD Medications Due to Manufacturing Delays

By January 22, 2018

Quillivant XR and Quillichew ER are currently in short supply.

ADHD Medication Use Increasing Among Reproductive-Aged Women

By January 18, 2018

ADHD medication prescriptions are increasingly common among privately insured, reproductive-aged women.

Psychostimulant Use Linked to Preeclampsia, Preterm Birth

November 15, 2017

Small increased relative risk of preeclampsia, preterm birth; absolute risk increases are small

Acetaminophen Use During Pregnancy Linked to Offspring ADHD

By October 30, 2017

Results showed that after adjusting for maternal use of acetaminophen pre-pregnancy, familial risk and indications of acetaminophen use, the hazard ratio (HR) of ADHD with ≥29 days of acetaminophen use was 2.20 (95% CI; 1.50-3.24).

Prevalence of Nonmedical Amphetamine Use May Be Underreported

October 27, 2017

Researchers analyzed prevalence and correlates of discordant responses among past-year Adderall users, defined as reporting past-year nonmedical Adderall use but not past-year nonmedical amphetamine use.

Nationwide Availability of Cotempla XR-ODT for ADHD Announced

By October 02, 2017

Cotempla XR-ODT is a Schedule II controlled substance and is supplied as 8.6mg, 17.3mg, and 25.9mg strength orally-disintegrating tablets in cartons containing 5 blister cards of 6 tablets each.

Adzenys ER Approved for the Treatment of ADHD

By September 18, 2017

Adzenys ER is a once-daily extended-release liquid that does not need to be reconstituted or refrigerated.

Over 1 Million ADHD Patches Recalled Due to Liner Defect

By September 12, 2017

This error can make it difficult for patients and caregivers to remove the liners from the Daytrana patches.

Cotempla XR-ODT Available for Pediatric ADHD

By September 08, 2017

Cotempla XR-ODT contains methylphenidate, a central nervous system (CNS) stimulant.

FDA to Review Novel ADHD Treatment Dasotraline

By August 31, 2017

Two year-long studies assessing safety of dasotraline in children, adolescent and adult ADHD patients found the treatment to be generally well tolerated.

Neuroanatomic Abnormalities Identified in Those at High Risk for Autism

August 09, 2017

"In two genetically related cohorts at high risk for autism spectrum disorder, reciprocal neuroanatomic abnormalities were found and determined to be associated with cognitive and behavioral impairments," the authors write.

Treatment Shows Efficacy in Binge Eating Disorder

August 04, 2017

In both studies, more participants on LDX versus placebo were categorized as improved on the Clinical Global Impressions-Improvement starting at week one.

ADHD Med Adherence and Long-Term Substance Abuse Risk Examined

July 25, 2017

Patrick Quinn, PhD, of Indiana University Bloomington, and colleagues looked at data from 2,993,887 Americans with ADHD.

Maternal Antidepressant Use May Contribute to Offspring Autism

July 21, 2017

"Importantly, the absolute risk of autism was small, and, hypothetically, if no pregnant women took antidepressants, the number of cases that could potentially be prevented would be small," wrote the authors of the study.

PANS/PANDAS Treatment Guidelines Released

By July 20, 2017

"Immunomodulatory therapy should be considered early, because NSAIDs or a short course of oral corticosteroids may be sufficient for symptom remission in recent-onset cases, whereas those with long-standing symptoms often require more intensive and prolonged immunotherapeutic interventions," the authors write.

Mydayis Approved for the Treatment of ADHD

By June 21, 2017

Study data showed treatment with Mydayis significantly improved ADHD symptoms, as assessed by the ADHD-RS-IV and the Permanent Product Measure of Performance (PERMP), in both adolescents and adults.

Long-Acting, Orally-Disintegrating Tabs Approved for ADHD

By June 20, 2017

Patients using Cotempla XR-ODT showed a significant improvement in ADHD symptom control vs. placebo across the classroom day.

FDA Greenlights First Generic Version of ADHD Med

By May 31, 2017

Apotex, Teva, Aurobindo Pharma, and Glenmark are among the first companies to gain approval to market Atomoxetine Capsules in various strengths.

Parent-Mediated Intervention for At-Risk Autism Infants Shows Promise

May 12, 2017

Parents used this information to improve their baby's attention, communication, early language development, and social engagement.

ADHD Med Use May Help Cut Car Crashes

By May 10, 2017

The risk of motor vehicle crash for male patients was reduced by 38% during the months when medication was taken, compared to the months when it was not.

Novel DNRI Agent Improves ADHD Symptoms in Study

By April 21, 2017

Study data revealed children taking dasotraline 4mg daily had statistically significant and clinically meaningful improvement vs. placebo on the primary endpoint.

Does Prenatal Antidepressant Exposure Up Risk of ADHD, Autism?

By April 18, 2017

Autism spectrum disorder was diagnosed by age 15 in 5.28% of exposed vs. 2.14% of unexposed babies; 12.63% of exposed vs. 5.46% of unexposed babies were diagnosed with ADHD by age 15.

Vyvanse Available in Chewable Tablet Formulation

By April 14, 2017

The Food and Drug Administration initially approved the chewable tablet formulation in January 2017.

FDA Warns Against Products Claiming to Cure Autism

By April 12, 2017

The FDA has warned and/or taken action against a number of companies that have made improper claims about the intended use of their products in relation to treating autism or symptoms of autism.